Patents by Inventor Shenghui Li

Shenghui Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250108537
    Abstract: The present application relates to the technical field of processing of degradable materials, and in particular to a granulation processing method for a low-melt-index degradable material, and a shaped body prepared thereby. The granulation processing method for the degradable material provided by the present invention comprises: reducing the temperature of a screw rod for multiple times and increasing the rotating speed of the screw rod during an extrusion crystallization granulation process. The granulation processing method provided by the present invention is beneficial to improving the crystallization rate of the material during the granulation processing process, and reduces the influence caused by shear heat and relatively high processing temperature, thereby obtaining a granular material having a lower melt index.
    Type: Application
    Filed: May 19, 2023
    Publication date: April 3, 2025
    Applicants: SHANGHAI BLUEPHA MICROBIOLOGY TECHNOLOGY CO., LTD., JIANGSU LANSU BIOMATERIAL CO., LTD.
    Inventors: Yong XU, Shenghui LI, Zhiyu MA, Yiming MA, Teng LI, Haoqian ZHANG
  • Publication number: 20240208564
    Abstract: The present disclosure relates to transmission apparatuses, transmission apparatus adjustment methods, air tightness detection methods, and vehicles are provided. An example apparatus includes a drive pulley, a driven pulley and a transmission belt. The drive pulley is connected to the driven pulley by using the transmission belt. An axis of the drive pulley is configured to rotate around a first axis.
    Type: Application
    Filed: March 6, 2024
    Publication date: June 27, 2024
    Inventor: Shenghui LI
  • Patent number: 10100360
    Abstract: Biomarkers for diabetes and usages thereof are provided. And the biomarkers are nucleotides having polynucleotide sequences defined in SEQ ID NOs: 1-50.
    Type: Grant
    Filed: June 5, 2013
    Date of Patent: October 16, 2018
    Assignees: BGI SHENZHEN, BGI SHENZHEN CO., LIMITED
    Inventors: Shenghui Li, Qiang Feng, Zhuye Jie, Dongya Zhang, Junjie Qin, Jun Wang, Jian Wang, Huanming Yang
  • Publication number: 20150376697
    Abstract: A method and system to determine biomarkers related to abnormal condition in a subject are provided, comprising:sequencing nucleic acid samples from a first and a second subject in order to obtain multiple sequences respectively consisting of the first and the second sequencing results, wherein the first subject is in the abnormal condition; and the second subject is not in the abnormal condition; and the nucleic acid samples from the first and the second subject are both isolated from the samples of the same type; and the first and the second subject belong to the same species; and determining the biomarkers related to the abnormal condition in the subject based on the difference between the first and the second sequencing results.
    Type: Application
    Filed: August 22, 2012
    Publication date: December 31, 2015
    Applicants: BGI-Shenzhen, BGI Shenzhen, Co., Limited
    Inventors: Shenghui Li, Junjie Qin, Jianfeng Zhu, Dongya Zhang, Zhuye Jie, Jun Wang, Jian Wang, Huanming Yang
  • Publication number: 20150292011
    Abstract: Biomarkers for diabetes and usages thereof are provided. And the biomarkers are nucleotides having polynucleotide sequences defined in SEQ ID NOs: 1-50.
    Type: Application
    Filed: June 5, 2013
    Publication date: October 15, 2015
    Inventors: Shenghui Li, Qiang Feng, Zhuye Jie, Dongya Zhang, Junjie Qin, Jun Wang, Jian Wang, Huanming Yang
  • Publication number: 20150242565
    Abstract: The present teachings relate to analysis of a sample including a plurality of species. In one example, sequences of fragments of polynucleotides of the sample are obtained. A reference set comprising a plurality of sequences is obtained. An initial bin for each of the plurality of sequences of the reference set is determined based on a relative abundance of each sequence of the reference set in the sample. At least one final bin is obtained by modifying the initial bins for the plurality of sequences based on a model.
    Type: Application
    Filed: August 1, 2012
    Publication date: August 27, 2015
    Applicants: BGI Shenzhen, BGI Shenzhen Co., Limited
    Inventors: Shenghui Li, Qiang Feng, Junjie Qin, Jianfeng Zhu, Yuanlin Guan, Jun Wang, Jian Wang, Huanming Yang
  • Publication number: 20150211053
    Abstract: Biomarkers for diabetes and usages thereof are provided. And the biomarkers are Akkermansia muciniphila, Bacteroides intestinalis, Bacteroides sp. 20_3, Clostridium bolteae, Clostridium hathewayi, Clostridium ramosum, Clostridium sp. HGF2, Clostridium symbiosum, Desulfovibrio sp. 3_1_syn3, Eggerthella lenta, Escherichia coli, Clostridiales sp. SS3/4, Eubacterium rectale, Faecalibacterium prausnitzii, Haemophilus parainfluenzae, Roseburia intestinalis and Roseburia inulinivorans.
    Type: Application
    Filed: September 3, 2012
    Publication date: July 30, 2015
    Applicant: BGI-Shenzhen
    Inventors: Shenghui Li, Qiang Feng, Junjie Qin, Jianfeng Zhu, Dongya Zhang, Zhuye Jie, Jun Wang, Jian Wang, Huanming Yang
  • Publication number: 20150037286
    Abstract: The present invention provides use of Roseburia in the preparation of composition for prevention and/or treatment of obesity related diseases. Also provided are a composition used in the treatment and prevention for obesity related diseases, comprising pharmaceutical, drink, food, and/or animal feed composition, etc; and a method of reducing body weight and/or blood glucose.
    Type: Application
    Filed: October 16, 2014
    Publication date: February 5, 2015
    Inventors: Junjie Qin, Shenghui Li, Jianfeng Zhu, Xiaoping Li, Suisha Liang, Jun Wang, Jian Wang, Huanming Yang, Qiang Feng
  • Publication number: 20140227227
    Abstract: The present invention provides use of Roseburia in the preparation of composition for prevention and/or treatment of obesity related diseases. Also provided are a composition used in the treatment and prevention for obesity related diseases, comprising pharmaceutical, drink, food, and/or animal feed composition, etc; and a method of reducing body weight and/or blood glucose.
    Type: Application
    Filed: December 22, 2011
    Publication date: August 14, 2014
    Applicant: BGI Shenzhen Co., Limited
    Inventors: Junjie Qin, Shenghui Li, Jianfeng Zhu, Xiaoping Li, Suisha Liang, Jun Wang, Jian Wang, Huanming Yang, Qiang Feng
  • Patent number: D709604
    Type: Grant
    Filed: November 26, 2012
    Date of Patent: July 22, 2014
    Assignees: Hisense Kelon Electrical Holdings Co., Ltd., Guangdong Kelon Air Conditioner Co., Ltd.
    Inventors: Peiran Qin, Haoping Wang, Lei Wang, Shenghui Li, Ye He